Alzheimers Disease Therapeutics and Diagnostics Market

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
Alzheimers Disease Therapeutics and Diagnostics Market aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Therapeutics and Diagnostics. Alzheimers Disease Therapeutics and Diagnostics Market contains market size and forecasts of Alzheimer's Disease Therapeutics and Diagnostics in global, including the following market information:
Global Alzheimer's Disease Therapeutics and Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Alzheimer's Disease Therapeutics and Diagnostics market was valued at US$ 3722.7 million in 2022 and is projected to reach US$ 4113.3 million by 2029, at a CAGR of 1.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Alzheimer?s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
We surveyed the Alzheimer's Disease Therapeutics and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer's Disease Therapeutics and Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Alzheimer's Disease Therapeutics and Diagnostics Market Segment Percentages, by Type, 2022 (%)
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests
Global Alzheimer's Disease Therapeutics and Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Alzheimer's Disease Therapeutics and Diagnostics Market Segment Percentages, by Application, 2022 (%)
Drugs Market
Diagnostics Market
Global Alzheimer's Disease Therapeutics and Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Alzheimer's Disease Therapeutics and Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer's Disease Therapeutics and Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Alzheimer's Disease Therapeutics and Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alzheimer's Disease Therapeutics and Diagnostics, market overview.
Chapter 2: Global Alzheimer's Disease Therapeutics and Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Alzheimer's Disease Therapeutics and Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alzheimer's Disease Therapeutics and Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.